TD Cowen Maintains Hold on Calumet, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 63.2%

Neg 0% Neu 0% Pos 63.2%

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.